of dirty clouds.
By then Sterling Biotech’s stock had been halted pending disclosure. Two banks had issued formal demand notices. A regulator wanted original books, not summaries. Someone on the board had leaked internal emails to the press. Not us. Somebody scared enough to save their own skin.
The first headline hit at 6:11.
STERLING HOLDINGS FACES continue reading …
